261 related articles for article (PubMed ID: 25884357)
1. A qualitative study trialling the acceptability of new hepatitis C prevention messages for people who inject drugs: symbiotic messages, pleasure and conditional interpretations.
Treloar C; Newland J; Maher L
Harm Reduct J; 2015 Mar; 12():5. PubMed ID: 25884357
[TBL] [Abstract][Full Text] [Related]
2. Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs.
Treloar C; Rance J; Yates K; Mao L
Int J Drug Policy; 2016 Jan; 27():138-45. PubMed ID: 26394538
[TBL] [Abstract][Full Text] [Related]
3. Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene.
Gunn J; McNally S; Ryan J; Layton C; Bryant M; Walker S; O'Mahony C; Pedrana A
Int J Drug Policy; 2021 Oct; 96():103387. PubMed ID: 34330571
[TBL] [Abstract][Full Text] [Related]
4. Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study.
Williams B; Howell J; Doyle J; Thompson AJ; Draper B; Layton C; Latham N; Bramwell F; Membrey D; Mcpherson M; Roney J; Stoové M; Hellard ME; Pedrana A
Int J Drug Policy; 2019 Oct; 72():91-98. PubMed ID: 31129023
[TBL] [Abstract][Full Text] [Related]
5. Harm reduction workers and the challenge of engaging couples who inject drugs in hepatitis C prevention.
Treloar C; Rance J; Bryant J; Fraser S
Drug Alcohol Depend; 2016 Nov; 168():170-175. PubMed ID: 27665209
[TBL] [Abstract][Full Text] [Related]
6. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J;
Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881
[TBL] [Abstract][Full Text] [Related]
7. Tensions in relation: How peer support is experienced and received in a hepatitis C treatment intervention.
Bonnington O; Harris M
Int J Drug Policy; 2017 Sep; 47():221-229. PubMed ID: 28606391
[TBL] [Abstract][Full Text] [Related]
8. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia.
Coupland H; White B; Bates A; Park JN; Iversen J; Maher L
Drug Alcohol Rev; 2019 Feb; 38(2):177-184. PubMed ID: 30652363
[TBL] [Abstract][Full Text] [Related]
9. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
Bruggmann P; Grebely J
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
[TBL] [Abstract][Full Text] [Related]
10. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
[TBL] [Abstract][Full Text] [Related]
11. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.
MacArthur GJ; van Velzen E; Palmateer N; Kimber J; Pharris A; Hope V; Taylor A; Roy K; Aspinall E; Goldberg D; Rhodes T; Hedrich D; Salminen M; Hickman M; Hutchinson SJ
Int J Drug Policy; 2014 Jan; 25(1):34-52. PubMed ID: 23973009
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden.
Kågström E; Lannergård A; El Khosht J; Lörelius P; Månflod J; Strömdahl S
Harm Reduct J; 2023 Jun; 20(1):77. PubMed ID: 37328868
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia.
Mukherjee TI; Pillai V; Ali SH; Altice FL; Kamarulzaman A; Wickersham JA
Int J Drug Policy; 2017 Sep; 47():144-152. PubMed ID: 28652072
[TBL] [Abstract][Full Text] [Related]
14. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
[TBL] [Abstract][Full Text] [Related]
15. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs.
Childs E; Assoumou SA; Biello KB; Biancarelli DL; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Bazzi AR
Harm Reduct J; 2019 Feb; 16(1):14. PubMed ID: 30744628
[TBL] [Abstract][Full Text] [Related]
17. Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: systematic review of qualitative research.
Jones L; Atkinson A; Bates G; McCoy E; Porcellato L; Beynon C; McVeigh J; Bellis MA
Int J Drug Policy; 2014 Mar; 25(2):204-11. PubMed ID: 24332457
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review.
Abdul-Quader AS; Feelemyer J; Modi S; Stein ES; Briceno A; Semaan S; Horvath T; Kennedy GE; Des Jarlais DC
AIDS Behav; 2013 Nov; 17(9):2878-92. PubMed ID: 23975473
[TBL] [Abstract][Full Text] [Related]
19. "It gives me a sense of belonging": providing integrated health care and treatment to people with HCV engaged in a psycho-educational support group.
Woolhouse S; Cooper E; Pickard A
Int J Drug Policy; 2013 Nov; 24(6):550-7. PubMed ID: 23860471
[TBL] [Abstract][Full Text] [Related]
20. Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020).
Palmateer N; Hamill V; Bergenstrom A; Bloomfield H; Gordon L; Stone J; Fraser H; Seyler T; Duan Y; Tran R; Trayner K; Biggam C; Smith S; Vickerman P; Hickman M; Hutchinson S
Int J Drug Policy; 2022 Nov; 109():103872. PubMed ID: 36202039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
